Clinical Trial: Phase 3 Trial of Tarlatamab (SC vs IV) In Extensive Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy (China)

China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Phase 3 Trial of Tarlatamab (SC vs IV) In Extensive Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131273

Registration Time: 2026/08/31

Type: Interventional study

Primary Sponsor: Shanghai Pulmonary Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340025

Published by HT Digital Content Services with permission from Health Daily Digest....